Nuclear localization of endothelin-converting enzyme-1 - Subisoform specificity

被引:23
|
作者
Jafri, F
Ergul, A [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Clin Pharm CJ1020, Augusta, GA 30912 USA
[2] Univ Georgia, Clin & Expt Therapeut Program, Augusta, GA USA
关键词
endothelin; subcellular localization; high glucose;
D O I
10.1161/01.ATV.0000099787.21778.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The biosynthesis of endothelin-1 (ET-1), the most potent vasoconstrictor with mitogenic properties, involves the processing of intermediate protein big ET-1 by a unique metalloprotease, endothelin-converting enzyme-1 (ECE-1). ECE-1 has 4 subisoforms that possess the same catalytic properties but different localization patterns on the plasma membrane and cytosol. We investigated the trafficking of ECE-1 subisoforms using green fluorescent protein - tagged recombinant enzymes in target and nontarget cells. Methods and Results - ECE-1 localization was studied using confocal microscopy, which provides evidence for the first time that both ET-1 and ECE-1a are also found in the nuclear compartment in transiently transfected cells as well as in native endothelial cells that endogenously possess the ET system. In cells maintained in high-glucose medium, ECE-1a - specific staining shifted from plasma membrane to intracellular compartments. ECE-1b subisoform, however, is mainly in the cytosolic compartment, indicating a subisoform specificity for nuclear localization. Conclusions - Our findings define a novel localization pattern for the ET system, which may be differentially regulated under pathophysiological conditions.
引用
收藏
页码:2192 / 2196
页数:5
相关论文
共 50 条
  • [1] Localization of endothelin-converting enzyme-1 in human kidney
    Pupilli, C
    Romagnani, P
    Lasagni, L
    Bellini, F
    Misciglia, N
    Emoto, N
    Yanagisawa, M
    Rizzo, M
    Mannelli, M
    Serio, M
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (05) : F749 - F756
  • [2] Endothelin-converting enzyme-1 in cancer aggressiveness
    Tapia, Julio C.
    Niechi, Ignacio
    CANCER LETTERS, 2019, 452 : 152 - 157
  • [3] Expression and localization of endothelin-converting enzyme-1 in human prostate cancer
    Dawson, Louise A.
    Maitland, Norman J.
    Berry, Paul
    Turner, Anthony J.
    Usmani, Badar A.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 1106 - 1110
  • [4] Immunohistochemical localization of endothelin-1 and endothelin-converting enzyme-1 in rat lung allografts
    McDermott, CD
    Shennib, H
    Giaid, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S27 - S30
  • [5] Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells
    Hunter, Alison R.
    Turner, Anthony J.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (06) : 718 - 722
  • [6] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT ENDOTHELIN-CONVERTING ENZYME-1
    EMOTO, N
    TAKEDA, S
    YANAGISAWA, M
    CIRCULATION, 1995, 92 (08) : 3043 - 3043
  • [7] Placental endothelin-converting enzyme-1 is decreased in preeclampsia
    McCormick, Anna
    Kristianto, Jasmin
    Wang, Xiaohu
    McIntosh, Jennifer
    Cruz, Meredith
    Hibbard, Judith U.
    Blank, Robert D.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 20 : 108 - 110
  • [8] Functional significance of the isoforms of endothelin-converting enzyme-1
    Brown, CD
    Barnes, K
    Turner, AJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S26 - S27
  • [9] Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1
    Takayanagi, R
    Liu, W
    Ito, T
    Ohnaka, K
    Nawata, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S62 - S63
  • [10] Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1
    Carson, JA
    Ansai, T
    Awano, S
    Yu, WX
    Takehara, T
    Turner, AJ
    CLINICAL SCIENCE, 2002, 103 : 90S - 93S